Skip to main content
. 2020 Mar 6;10:4179. doi: 10.1038/s41598-020-61129-5

Table 2.

Subjects absorbed dose and effective dose of 99mTc-HYNIC-PSMA.

Target organ Absorbed dose (mGy/MBq)
Adrenals 2.84E-03 ± 3.78E-04
Brain 4.12E-04 ± 2.34E-04
Breasts 8.04E-04 ± 2.97E-04
Gallbladder 2.31E-03 ± 3.66E-04
Lower large intestine wall 2.60E-03 ± 3.87E-04
Small intestine wall 1.88E-03 ± 1.99E-04
Stomach wall 1.58E-03 ± 2.75E-04
Upper large intestine wall 1.71E-03 ± 2.20E-04
Heart wall 3.87E-03 ± 1.53E-03
Kidneys 2.87E-02 ± 1.53E-03
Liver 3.76E-03 ± 6.06E-04
Lungs 5.41E-03 ± 2.10E-03
Muscle 1.28E-03 ± 2.05E-04
Pancreas 2.49E-03 ± 3.16E-04
Red marrow 1.32E-03 ± 2.43E-04
Osteogenic cells 2.38E-03 ± 7.75E-04
Skin 6.00E-04 ± 1.61E-04
Spleen 6.68E-03 ± 2.20E-03
Salivary glands 1.28E-02 ± 4.25E-03
Testes 1.65E-03 ± 2.56E-04
Thymus 1.21E-03 ± 4.40E-04
Thyroid 6.20E-04 ± 3.10E-04
Urinary bladder wall 3.53E-02 ± 9.01E-03
Total body 1.54E-03 ± 2.43E-04
Effective dose (mSv/MBq) 3.72E-03 ± 4.50E-04

(Data are mean ± SD; n = 5).